1269815-49-7

Upstream product

• 659731-48-3 5-chloro-2-fluoro-4-iodopyridine 
• 380430-68-2 3-(tert-butoxycarbonylamino)phenylboronic acid 

Downstream Products

• 1269815-50-0 [3-(5-chloro-2-fluoro-pyridin-4-yl)-phenyl]-(tetrahydro-pyran-4-ylmethyl)-carbamic acid tert-butyl ester 
• 1377698-71-9 (1s,4s)-4-(4-(3-(tert-butoxycarbonyl((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)-5-chloropyridin-2-ylamino)cyclohexyl methanesulfonate 
• 1377698-66-2 tert-butyl 3-(5-chloro-2-((1s,4s)-4-hydroxycyclohexylamino)pyridin-4-yl)phenyl((tetrahydro-2H-pyran-4-yl)methyl)carbamate 
• 1269815-48-6 [3-(2-amino-5-chloro-pyridin-4-yl)-phenyl]-(tetrahydro-pyran-4-ylmethyl)-carbamic acid tert-butyl ester 
• 1269815-19-1 (R)-N-(5-chloro-4-(3-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)pyridin-2-yl)piperidine-3-carboxamide 
• 1269815-54-4 (R)-1-(tert-butyl-3-(4-(3-(tert-butoxycarbonyl)((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)-5-chloropyridin-2-ylcarbamoyl)piperidine-1-carboxylate 

Relevant academic research and scientific papers

PHENYL-HETEROARYL AMINE COMPOUNDS AND THEIR USES

The present invention provides a compound of formula (I): and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by CDK9 using the compounds of Formula I, and pharmaceutical compositions comprising such compounds

HETEROARYL COMPOUNDS AS KINASE INHIBITORS

The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor